December 7, 2022 Marc Blaustein mblaustein@finchtherapeutics.com Dear Marc,Employment Agreement • March 25th, 2024 • Finch Therapeutics Group, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledMarch 25th, 2024 Company IndustryThe purpose of this letter is to amend the Employment Agreement by and between Finch Therapeutics Group, Inc. (the “Company”) and you dated as of September 8, 2021 (the “Employment Agreement”), effective as of April 30, 2022 (the “Effective Date”). Capitalized terms used but not defined in this letter will have the meanings set forth in the Employment Agreement.
December 7, 2022 Marc Blaustein mblaustein@finchtherapeutics.com Dear Marc,Employment Agreement • March 23rd, 2023 • Finch Therapeutics Group, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledMarch 23rd, 2023 Company IndustryThe purpose of this letter is to amend the Employment Agreement by and between Finch Therapeutics Group, Inc. (the “Company”) and you dated as of September 8, 2021 (the “Employment Agreement”), effective as of April 30, 2022 (the “Effective Date”). Capitalized terms used but not defined in this letter will have the meanings set forth in the Employment Agreement.